Potential mechanisms of moxonidine-induced ocular hypotension: Role of norepinephrine

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 6, 1997, Pages 489-496

  Chu, Teh Ching ^a   Socci, Robin R ^a   Ogidigben, Miller J ^a   Potter, David E ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; DOPAMINE; EFAROXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE RECEPTOR; MOXONIDINE; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; NONHUMAN; NORADRENALIN RELEASE; RABBIT; SUPERIOR CERVICAL GANGLION; TOPICAL DRUG ADMINISTRATION;

EID: 0031455737     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.489     Document Type: Article

References (21)

1. Potter, D.E. Adrenergic pharmacology of aqueous humor dynamics. Pharmacol. Rev. 269:133-153, 1981.
2. Potter, D.E. Drugs that alter autonomic nervous system function. In: Clinical Ophthalmic Pharmacology, Lamberts, D.W. and Potter, D.E., eds. Little, Brown Company, Boston/Toronto, 1987.
3. Ogidigben, M.J., Chu, T.C. and Potter, D.E. Ocular actions of moxonidine: A possible role for imidazoline receptors. J. Pharmacol. Exp. Therap., 269:897-904, 1994.
4. Noon, J.P., McAfee, D.A. and Roth, R.H. Norepinephrine release from nerve terminals within the rabbit superior cervical ganglion. Naunyn-Schmiedeberg's Arch. Pharmacol. 291:139-162, 1975.
5. Trope, G.E. and Rumley, A.G. Catecholamines in human aqueous humor. Invest. Ophthalmol. Vis. Sci. 26:399-401, 1985.
6. Cooper, R.L., Constable, I.J. and Davidson, L. Aqueous humor catecholamines. Curr. Eye Res. 3:809-813, 1984.
7. Liu, J.H.K. Concentration of norepinephrine in aqueous humor during transient decrease of intraocular pressure after superior cervical ganglionectomy. Invest. Ophthalmol. Vis. Sci. (ARVO Suppl) 33:1179, 1992.
8. Rowland, J.M., Sawyer, W.K., Tittel, J. and Ford, C.J. Studies on the circadian rhythm of IOP in rabbits: correlation with aqueous inflow and cAMP content. Curr. Eye Res. 6:201-206, 1986.
9. Kiuchi, Y. and Gregory, D.S. Rabbits have a circadian rhythm of aqueous humor cyclic AMP. Curr. Eye Res. 11:935-938, 1992.
10. Liu, J.H. and Gallar, J. In vivo cAMP level in rabbit iris-ciliary body after topical epinephrine treatment. Curr. Eye Res. 15(10):1025-1032, 1996.
11. Ogidigben, M.J., Chu, T.C. and Potter, D.E. Moxonidine-induced lowering of intraocular pressure change in norepinephrine/dopamine levels. Invest. Ophthalmol. Vis. Sci. (ARVO Suppl) 36:S723, 1995.
12. Socci, R.R., Ogidigben, M.J., Chu, T.C. and Potter, D.E. Functional evidence for imidazoline receptors on rabbit sympathetic neurons. Invest. Ophthalmol. Vis. Sci. (ARVO Suppl) 37:S837, 1996.
13. Gamache, P., Ryan, E., Svendsen, C., Murayama, K. and Acworth, I.N. Simultaneous measurement of monoamines, metabolites and amino acids in brain tissue and microdialysis perfusates. J. Chromatogr. 614:213-220, 1993.
14. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20(Suppl. 4), S1-S10, 1992.
15. Chan, C.K.S. and Head, G.A. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. J. Hypertension. 14:855-864, 1996.
16. Burke, J.A. and Potter, D.E. Ocular effects of a relatively selective alpha2 agonist (UK-14,304-18) in cats, rabbits and monkeys. Curr. Eye Res. 5:665-676, 1986.
17. 2) agonist, TNPA. J. Pharmacol. Exp. Therap. 267:822-827, 1993.
18. Potter, D.E. and Novack, G.D. Adrenergic pharmacology of anterior segment. In: Textbook of Ocular Pharmacology. Zimmerman et al., eds. Lippincott-Raven Publishers, New York, 1997.
19. Gherezghiher, T. and Koss, M.C. Quantitative assessment of ocular norepinephrine concentration in the rabbit using liquid chromatography with electrochemical detection. Ophthalmic Res. 17:65-71, 1985.
20. Martin, X.D., Malina, H.Z., Brennan, M.C., Hendrickson, H. and Lichter, P.R. The ciliary body -the third organ found to synthesize indolamines in humans. Eur. J. Ophthalmol. 2:67-72, 1992.
21. Tobin, A.B., Unger, W. and Osborne, N.N. Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J. Neurosci. 8(10):3713-3721, 1988.